Jefferies analyst Maury Raycroft reiterated a Buy rating and $20.00 price target on Kezer Life Sciences (NASDAQ: KZR) after the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE